CONCOURSE FINANCIAL GROUP SECURITIES, INC. - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
CONCOURSE FINANCIAL GROUP SECURITIES, INC. ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$000.00%
Q2 2023$000.00%
Q1 2023$000.00%
Q4 2022$000.00%
Q3 2022$000.00%
Q2 2022$000.00%
Q1 2022$0
-100.0%
0
-100.0%
0.00%
Q4 2021$8,000
-42.9%
5000.0%0.00%
-100.0%
Q3 2021$14,000
-6.7%
5000.0%0.00%0.0%
Q2 2021$15,000
+7.1%
5000.0%0.00%0.0%
Q1 2021$14,0000.0%5000.0%0.00%0.0%
Q4 2020$14,000
+7.7%
5000.0%0.00%0.0%
Q3 2020$13,000
+8.3%
5000.0%0.00%0.0%
Q2 2020$12,0005000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$000.00%
Q2 2019$000.00%
Q1 2019$000.00%
Q4 2018$000.00%
Q3 2018$000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$48,000,00065.50%
Essex Woodlands Management, Inc. 3,842,047$118,335,00025.90%
Rhenman & Partners Asset Management AB 203,181$6,258,0000.77%
EAM Global Investors LLC 44,898$1,383,0000.72%
Fosun International Ltd 319,313$9,835,0000.62%
EAM Investors, LLC 113,096$3,483,0000.58%
ArrowMark Colorado Holdings LLC 1,735,699$53,460,0000.53%
Perceptive Advisors 618,957$19,064,0000.53%
ESSEX INVESTMENT MANAGEMENT CO LLC 111,360$3,430,0000.45%
Schonfeld Strategic Advisors LLC 83,700$2,578,0000.19%
View complete list of REVANCE THERAPEUTICS INC shareholders